Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M342Revenue (TTM) $M43.6Net Margin (%)-257.8Altman Z-Score-6.0
Enterprise Value $M352EPS (TTM) $-1.3Operating Margin %-212.9Piotroski F-Score2
P/E(ttm)--Beneish M-Score-3.4Pre-tax Margin (%)-257.8Higher ROA y-yY
Price/Book38.310-y EBITDA Growth Rate %-17.1Quick Ratio3.8Cash flow > EarningsY
Price/Sales7.25-y EBITDA Growth Rate %19.3Current Ratio3.8Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-59.0Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-5,587.1Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M99.1ROIC % (ttm)-619.6Gross Margin Increase y-yN

Gurus Latest Trades with AGEN

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

AGEN is held by these investors:



AGEN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
ARMEN GARO HChairman & CEO 2017-04-12Buy100,000$3.352.99view
INCYTE CORP10% Owner 2017-02-14Buy10,000,000$6-42.5view
WIINBERG ULFDirector 2016-09-06Buy30,000$6.29-45.15view
ARMEN GARO HChairman & CEO 2016-05-09Buy100,000$3.188.49view
ARMEN GARO HChairman & CEO 2016-05-09Buy100,000$3.188.49view
Baysal OzerChief Business Officer 2016-05-05Buy2,250$3.111.29view
ARMEN GARO HChairman & CEO 2016-03-07Buy200,000$4.03-14.39view
ARMEN GARO HChairman & CEO 2015-12-29Sell219,576$4.59-24.84view
ARMEN GARO HChairman & CEO 2015-09-25Buy100,000$5.03-31.41view
Ballantyne Charles EvanCFO 2015-09-25Buy10,000$5.05-31.68view

Quarterly/Annual Reports about AGEN:

News about AGEN:

Articles On GuruFocus.com
Agenus to present safety results for anti-CTLA-4 antibody at ASCO 2017 Annual Meeting May 22 2017 
Agenus Reports First Quarter 2017 Financial Results and Provides Corporate Update May 04 2017 
Agenus to Report First Quarter 2017 Financial Results on May 4, 2017; Conference Call to Follow Apr 27 2017 
Phase 1/2 Clinical Trial of Agenus' anti-PD-1 Antibody Begins Apr 20 2017 
Agenus Commences Phase 1 Trial with Neoantigen Cancer Vaccine AutoSynVax™ Apr 05 2017 
Agenus Restructures Business to Sharpen Focus on Clinical Development of Cancer Therapies Mar 31 2017 
Insiders Roundup: Facebook, Twitter, Kellogg Feb 17 2017 
Weekly CEO Buys Highlights Mar 14 2016 
Paul Tudor Jones' Highest Performing Stocks Jul 13 2015 
Agenus Inc.: Ingeniously Designed Vaccines To Galvanized Tomorrow's Medicine Jul 25 2014 

More From Other Websites
ETFs with exposure to Agenus, Inc. : May 22, 2017 May 22 2017
Agenus to present safety results for anti-CTLA-4 antibody at ASCO 2017 Annual Meeting May 22 2017
Better Buy: Celldex Therapeutics, Inc. vs. Agenus Inc. May 21 2017
Agenus, Inc. :AGEN-US: Earnings Analysis: Q1, 2017 By the Numbers : May 9, 2017 May 09 2017
Agenus, Inc. – Value Analysis (NASDAQ:AGEN) : May 8, 2017 May 08 2017
Agenus (AGEN) Reports Narrower-than-Expected Loss in Q1 May 05 2017
Agenus, Inc. breached its 50 day moving average in a Bullish Manner : AGEN-US : May 5, 2017 May 05 2017
Here's Why Agenus Inc. Stock Is Climbing Today May 04 2017
Agenus reports 1Q loss May 04 2017
Agenus Reports First Quarter 2017 Financial Results and Provides Corporate Update May 04 2017
Investor Network: Agenus Inc. to Host Earnings Call May 04 2017
Agenus to Report First Quarter 2017 Financial Results on May 4, 2017; Conference Call to Follow Apr 27 2017
First malaria vaccine to be tested in Africa, with boost from Lexington's Agenus Apr 24 2017
What's in Store for Agenus (AGEN) this Earnings Season? Apr 24 2017
Phase 1/2 Clinical Trial of Agenus' anti-PD-1 Antibody Begins Apr 20 2017
Why Is Agenus (AGEN) Down 16.8% Since the Last Earnings Report? Apr 11 2017
ETFs with exposure to Agenus, Inc. : April 10, 2017 Apr 10 2017
Agenus (AGEN) Sharpens Focus on Drug Development Programs Apr 05 2017
Agenus Commences Phase 1 Trial with Neoantigen Cancer Vaccine AutoSynVax™ Apr 05 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)